Simplex Trading’s BIOATLA INC BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4
Closed -$32 9293
2026
Q1
$32 Sell
4
-8
-67% -$94 ﹤0.01% 8915
2025
Q4
$340 Buy
+12
New +$470 ﹤0.01% 8206
2024
Q4
Sell
-64
Closed -$5K 8497
2024
Q3
$5K Buy
64
+34
+113% +$2.85K ﹤0.01% 7576
2024
Q2
$2K Buy
+30
New +$3.57K ﹤0.01% 8223
2023
Q3
Sell
-82
Closed -$12K 8658
2023
Q2
$12K Sell
82
-26
-24% -$4.47K ﹤0.01% 7217
2023
Q1
$14K Buy
108
+66
+157% +$11.9K ﹤0.01% 7232
2022
Q4
$17K Sell
42
-2
-5% -$830 ﹤0.01% 7019
2022
Q3
$16K Sell
44
-210
-83% -$68.7K ﹤0.01% 7734
2022
Q2
$36K Buy
254
+16
+7% +$2.55K ﹤0.01% 6904
2022
Q1
$59K Buy
238
+236
+11,800% +$98.7K ﹤0.01% 6900
2021
Q4
$1K Buy
+2
New +$2.56K ﹤0.01% 10139

Other funds holding BCAB

Simplex Trading's BCAB Position: Q2 2026 in Review

Simplex Trading sold out of BIOATLA INC (BCAB) in Q2 2026, closing a stake of 1,478 shares — an estimated $11.9K sold.

Simplex Trading first reported a position in BCAB in Q4 2021 and held it in 15 quarters. The position peaked at $167K in Q4 2021. 21 funds tracked by Wall St. Rank hold BCAB as of Q2 2026.

  • Simplex Trading reported no remaining BIOATLA INC position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 1,478 BIOATLA INC shares in Q2 2026, an estimated $11.9K.
  • Simplex Trading first reported a position in BIOATLA INC in Q4 2021 and held it in 15 quarters.
  • Simplex Trading's BIOATLA INC position peaked at $167K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held BIOATLA INC as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.